Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Clinical trial NCT01244191 · TERMINATED

Trial details

NCT number: NCT01244191
Sponsor: Daiichi Sankyo
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Squamous, Non-small-cell Lung Cancer

Start date: 2011-01-11
Primary completion: 2012-12-15
Enrollment: 1048

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.